Immunological impact of an additional early measles vaccine in Gambian children: Responses to a boost at 3 years
Open Access
- 28 March 2012
- Vol. 30 (15) , 2543-2550
- https://doi.org/10.1016/j.vaccine.2012.01.083
Abstract
No abstract availableKeywords
Funding Information
- Medical Research Council (UK) (SCC 948)
This publication has 34 references indexed in Scilit:
- Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85APLOS ONE, 2009
- Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trialBMJ, 2008
- Cytomegalovirus infection induces T‐cell differentiation without impairing antigen‐specific responses in Gambian infantsImmunology, 2008
- Risk Factors for and Clinical Outcome of Congenital Cytomegalovirus Infection in a Peri-Urban West-African Birth CohortPLOS ONE, 2007
- Limited Contribution of Humoral Immunity to the Clearance of Measles Viremia in Rhesus MonkeysThe Journal of Infectious Diseases, 2004
- Humoral and Cell‐Mediated Immune Responses to an Early 2‐Dose Measles Vaccination Regimen in the United StatesThe Journal of Infectious Diseases, 2004
- Lack of Evidence of Measles Virus Shedding in People with Inapparent Measles Virus InfectionsThe Journal of Infectious Diseases, 2004
- A code of best practice for disease control programmes to avoid damaging health care services in developing countriesThe International Journal of Health Planning and Management, 2003
- Serologic status and measles attack rates among vaccinated and unvaccinated children in rural SenegalThe Pediatric Infectious Disease Journal, 1995
- Changes in Cytokine Production after Measles Virus Vaccination: Predominant Production of IL-4 Suggests Induction of a Th2 ResponseClinical Immunology and Immunopathology, 1993